Top compounds associated with response to TMEM110


Feature Type Standardized
Nominal ANOVA
mRNA barasertib CTRPv2 pan-cancer AAC 0.088 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.01
mRNA Gemcitabine gCSI pan-cancer AAC 0.14 0.02
mRNA ML083 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.095 0.02
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA PDMP CTRPv2 pan-cancer AAC -0.096 0.02
Download CSV